Z.M. Harris

Yale University — United States

Medicine · Health Sciences

6h-index681citations29works7.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(6), Neonatal Respiratory Health Research(5), Bacteriophages and microbial interactions(5), Chronic Obstructive Pulmonary Disease (COPD) Research(3), Respiratory Support and Mechanisms(3)

Publications29 total

Prevalence, Production and the Role of <i>Staphylococcus aureus</i> Superantigens in Cystic Fibrosis Lung Disease
2025Open Access
Epidermal Growth Factor Receptor Regulates Beclin-1 and Autophagy in Hyperoxic Acute Lung Injury
American Journal of Respiratory and Critical Care Medicine·2025
Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis
Nature Medicine·2025· 51 citedOpen Access
Potential missed opportunities for the diagnosis, treatment, and follow-up of eosinophilic esophagitis: analysis of endoscopic food impaction management
Annals of Esophagus·2024· 2 citedOpen Access
Epidermal Growth Factor Receptor Regulates Beclin-1 in Hyperoxic Acute Lung Injury
2024· 1 citedOpen Access
Age Is Just a Number: An Atypical Case of Granulomatosis With Polyangitis in an Elderly Patient
2024
Epidermal Growth Factor Receptor Regulates Beclin-1 in Hyperoxia-Induced Lung Injury
2024
Cystic Fibrosis Bacteriophage Study at Yale (CYPHY)
2024· 3 cited
41 CYstic Fibrosis bacterioPHage study at Yale (CYPHY)
Journal of Cystic Fibrosis·2023· 1 citedOpen Access
Protracted Pulmonary Inflammation in IFN-gamma Deficient Mice Recovering From Cytokine Release Syndrome
2023· 1 cited
Epidermal Growth Factor Receptor Regulates Beclin-1 in Hyperoxia-Induced Lung Injury
2023
A Novel Zinc (II) Porphyrin Is Synergistic with PEV2 Bacteriophage against Pseudomonas aeruginosa Infections
Antibiotics·2023· 4 citedOpen Access
Transitions of Care in Cystic Fibrosis
Clinics in Chest Medicine·2022· 5 cited
IFN- <b>γ</b> is Protective in Cytokine Release Syndrome-associated Extrapulmonary Acute Lung Injury
American Journal of Respiratory Cell and Molecular Biology·2022· 13 citedOpen Access
Epidermal Growth Factor Receptor (EGFR) Modulates Apoptosis in Hyperoxia-Induced Lung Injury
2022
Lipopolysaccharide Targeted Bacteriophage Therapy Deceases Lung Inflammation in Cystic Fibrosis
2022Open Access
Epidermal Growth Factor Receptor Inhibition Is Protective in Hyperoxia‐Induced Lung Injury
Oxidative Medicine and Cellular Longevity·2022· 8 citedOpen Access
514: Novel zinc porphyrin antibiotic shows activity against Pseudomonas in vivo
Journal of Cystic Fibrosis·2021Open Access
Bacteriophage Decrease Cystic Fibrosis Lung Inflammation
2021Open Access
Epidermal Growth Factor Receptor (EGFR) Modulates Apoptosis via ERK1/2 in Hyperoxia-Induced Lung Injury
2021Open Access
page 1 of 2Next →

Frequent Co-authors

Jonathan L. Koff(20), G.L. Stanley(13), Buqu Hu(12), Ying Sun(10), Govindarajan Rajagopalan(9), John Joerns(8), G. Rajagopalan(7), Benjamin K. Chan(6), Gail Stanley(6), Lokesh Sharma(6), Derya Unutmaz(6), Maor Sauler(6), Min‐Jong Kang(6), Barbara J. Clark(6), Kaitlyn E. Kortright(5), Paul E. Turner(5), Edward P. Manning(5), Hyung J. Chun(5), A. Korde(4), L. Placek(4)